Profilo
Linda Basse worked as a Medical Director at Genmab A, Topotarget A, and Zealand Pharma A.
She also served as the Chief Medical Officer at Medivir AB from 2018 to 2020.
Dr. Basse holds a doctorate degree from the University of Copenhagen.
Precedenti posizioni note di Linda Basse
| Società | Posizione | Fine |
|---|---|---|
| MEDIVIR AB | Chief Tech/Sci/R&D Officer | 30/09/2020 |
| ZEALAND PHARMA A/S | Chief Tech/Sci/R&D Officer | - |
| TOPOTARGET A/S | Chief Tech/Sci/R&D Officer | - |
| GENMAB A/S | Chief Tech/Sci/R&D Officer | - |
Formazione di Linda Basse
| University of Copenhagen | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GENMAB A/S | Health Technology |
| MEDIVIR AB | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| Aziende private | 1 |
|---|---|
Topotarget A/S
 Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
- Borsa valori
- Insiders
- Linda Basse
